Gerresheimer offers a complete package of primary packaging for biologics

Pack and administer biologics safely

67
Gerresheimer
Photo - Gerresheimer

The most important trend forecast by pharmaceutical experts is the continuing, worldwide increasing demand for biological drugs and biosimilars. With the recently founded, Gx Biological Solutions organization, Gerresheimer has installed a dedicated team to serve the highly specific requirements in the biological play field.

The global biopharmaceuticals market is driven by various factors, such as the increase in the elderly population, surge in the prevalence of chronic diseases like cancer and diabetes, and growth in the adoption of biopharmaceuticals globally. Furthermore, a rise in strategic collaborations among biopharmaceuticals companies is also anticipated to supplement the growth of the biopharmaceutical industry.

Biological drugs are specifically being used to treat, for example, rheumatism, diabetes, or cancer and are usually administered parenterally. They differ from conventional drugs in their molecular structure. Hence special demands on the primary packaging are to be taken care of. Gerresheimer has developed a complete package of services and products for these biological drugs and biosimilars. This includes a dedicated, innovative product portfolio consisting of specialty syringes and vials, safety devices, and more that meet the specific requirements of this continuously growing market segment. At the same time, Gerresheimer also offers a wide range of services, especially for small and medium-sized biotech companies. Whether it is advised on the right primary packaging to be used in the appropriate clinical phase or support with approval and regulatory processes, lab services, and much more.

Gx Biological Solutions – new founded team of specialists

At Pharmapack 2020 in Paris, Gerresheimer has presented its products for the safe, innovative and sustainable packaging of biologicals. “We want to offer our customers in the pharmaceutical industry with customized packaging solutions for their biologics so that they can be assured that all of their requirements are met 100%,” said Stefan Verheyden, Global vice president of Gx Biological Solutions team.

Small Batch Production in Germany

As a leading manufacturer of syringes, injection vials as well as cartridges and administration systems, Gerresheimer covers a very broad spectrum for the parenteral administration of biologicals within its portfolio. Smaller batch sizes are often requested when filling biological products. Hence Gerresheimer has invested in a small batch production facility in Wackersdorf – Germany. When the filled biological agent is sensitive to its storage environment, the container must be individually adapted to its properties. During the clinical development phase, Gerresheimer experts can support with advice on the right primary packaging, syringe, or drug delivery device, as well as with regulatory approval processes and much more.

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now

LEAVE A REPLY

Please enter your comment!
Please enter your name here